Medical Health & Life Science Research News

Research report explores the Global drug screening market trends and outlook 2017-2024

The global drug screening market is segmented on the basis of product and services, sample type, and geography.

- Advertising -

According to Data Bridge Market Research new Market report “the global drug screening market accounted to USD 5.7 billion in 2016 at a CAGR of 12.50% during the forecast period of 2017 to 2024."

For Sample of the Report @ databridgemarketresearch.com/reque…-screening-market

Browse Detailed Report @ databridgemarketresearch.com/repor…screening-market/

Based on Products and Services Type:

  • Immunoassay Analyzers
  • Chromatography
  • Breath Analyzers
  • Rapid Testing Devices
  • Assay Kits
  • Reagent

Based on Sample Type:

  • Urine,
  • Breath
  • Saliva
  • Hair
  • Blood
  • Skin
  • Sweat

Access Report: databridgemarketresearch.com/speak…-screening-market

Based on geography the market is segmented into 5 geographical regions such as North America, Europe, Asia-Pacific, South America, Middle East and Africa. The geographical regions are further segmented into major countries such as U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others.

In 2017, North America is expected to dominate the market.

- Advertising -

The Global Drug Screening Market Report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.

Some of the major players operating in global drug screening market are Siemens Healthcare GmbH (Germany), Quest Diagnostics Incorporated (U.S.), Alere (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Laboratory Corporation of America Holdings (U.S.), Abbott (U.S.),  Hoffmann -La Roche Ltd(Switzerland), BioMerieux SA (France),  Express Diagnostics Int’l, Inc. (U.S.), Drägerwerk AG & Co. KGaA (Germany), Bio-Rad Laboratories Inc. (U.S), Biomedical Diagnostics (Belgium),  CannAmm (Canada), MPD, Inc. (U.S.), Danaher (U.S.), Synergy Health plc. (U.K),Agilent Technologies (U.S.), andShimadzu Corporation (Japan) among others.

Inquire report @ databridgemarketresearch.com/inqui…-screening-market

News From

Data Bridge Market ResearchData Bridge Market Research
Category: Market Research Publishers and RetailersCompany profile: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...